Introduction
For soldiers wounded on the battlefield, hemorrhage control is essential to survival.
Uncontrolled hemorrhage is the primary cause of death in the pre-hospital period for both military combat and civilian trauma incidents. Immediate action is highly effective in limiting patient mortality, since most bleeding fatalities occur within the first 30 minutes of the injury. It is generally accepted that hemostatic products for forward care in the battle zone must control bleeding quickly, be ready to use, simple to apply for first responders in combat situations, have a shelf life approaching 2 years, and prevent bacterial or viral transmission (Alam, Burris, DaCorta, & Rhee, 2005; Pusateri, Modrow et al., 2003) .
Those surviving severe injury have increased not only in a warfare environment, but also in a nonbattle emergency trauma environment with the help of innovative techniques and products that control and or stop bleeding as quickly as possible. Hemorrhage control technology has developed a variety of procedures, techniques, and products that stem or halt the flow of internal as well as external bleeding. The U.S. military uses some of the currently available hemorrhage control products on the battlefield and at field medical treatment facilities (MTFs).
Objectives and Methods
The Navy Technology Watch investigated and reported on methods and products that advertise hemorrhage control by searching the Internet, online publication databases, and brief telephone interviews with relevant investigators in the field, vendors, or Department of Defense (DoD) officials.
The requirements for a hemorrhage control products are not easily specified due to the diversity of combat injuries that cause traumatic bleeding, such as blunt trauma, blast wounds, lacerations and/or penetrating injuries. Also, the products must be applied in austere combat environments by first responders or wounded soldiers who can only carry a limited supplies (Alam et al., 2005) . The product should work rapidly and avoid complicating later treatment such as surgery. Products such as gauze dressings with ingredients from a variety of sources that facilitate control of external bleeding may be most useful to first responders. The most critical wounds are those for which a tourniquet or simple compression are not feasible, such as internal bleeding in the chest, abdomen, and pelvis, and closed extremity fractures that are not easily accessible. Therefore, internal bleeding usually requires rapid surgical intervention. Recent development efforts discussed below have investigated noninvasive methods, such as medications and ultrasound, that may locate and control severe internal bleeding (Basu, 2004) .
Most military medical personnel agree that use of candidate products in combat situations cannot wait for ideal data, such as randomized clinical trials with human patients (Alam et al., 2005) . The practical approach is to provide subject matter experts with the best available data, usually from animal models, and consideration of battlefield requirements. Subject matter experts can then develop a consensus for which products should be fielded for combat casualty care. The present report provides a summary of recent products and their strengths and weaknesses.
Until recently, first responders were limited to techniques that have not changed for decades: direct pressure, elevation, and tourniquets where possible, until the victim could receive fluid resuscitation and surgical repair of the wounds (Cloonan, 2004 ) . These techniques may be inadequate when wounds are in areas where compression and tourniquets cannot be applied, and the Combat Casualty Care Research Program has made the development of alternative, effective hemostatic dressings usable by first responders a priority . This initiative has contributed to the development of dressings and hemostatic agents, making use of a variety of ingredients.
Each type has strengths and weaknesses, which bear on its feasibility for military use.
The present review will examine the available research testing and comparing hemostatic products.
The objectives were to describe the available products per vendor claims and to:
• Underscore the pros and cons of each product
• Identify applicability to military environment
• Note adverse effects, reliability, and cost issues
• Provide a summary table of independently published research
Results
The results present information on how the products work and the products themselves, and a summary of a recent literature review of laboratory animal and other published studies on these products.
Current Methods
Current methods of wound intervention include absorbent pads containing clotting agents, topically applied clotting or bleeding-cessation agents in powder or granule form, pressure bandages, gauze, tourniquets for extremities, and trauma kits for wounds to the body.
These products meet a crucial need for both military and civilian casualties at the point of injury before evacuation, when time is critical. While they differ in composition and ingredients, includes work with physiologic sensors, blood products, dental injury and disease, surgical techniques, brain and spinal injuries, and survival strategies prior to evacuation (Basu, 2004) . In addition to clotting by means of exterior devices, Basu has described the relatively new frontier of battle area medical studies focused on noninvasive techniques, such as drugs and ultrasound.
Up until now, the only course of action has been surgery. For chest and abdominal bleeding, recent research has addressed three areas: hemostatic foam; high-intensity, focused ultrasound;
and recombinant activated factor VII, which is a genetically engineered version of a naturally occurring human blood clotting factor. However, most Army research into internal hemorrhage control has shifted to this third area of recombinant activated factor VII. This solution was previously developed for hemophiliacs to induce blood clotting. This method has been used on about 300 hospital patients in Israel after anecdotal evidence of its initial success in seriously wounded patients. In the field, it could add hours to survival time before evacuation. At present, none of these three solutions is suited for use by far-forward troops because of present size of the equipment needed, training issues, and lack of FDA approval. For the first two solutions, application is still too complex to be practical for first responders and combat lifesavers.
Product Reviews
For the purposes of hemostatic response in the field, products discussed during this investigation will concentrate on external utilization. The following products were evaluated by type of hemostatic agent, application methodology, cost considerations, and possible adverse effects. Vendor contact information is summarized in Appendix A. Zeolite. Granular zeolite is a substance derived from lava rocks. When this material is placed into a bleeding wound, it absorbs the water molecules in the blood and creates a high platelet concentration to promote clotting. This causes an exothermic reaction. Several U.S.
Navy physicians who served in Iraq report that this substance produces sufficient heat to cause burns to the skin if measures are not taken to wipe off water, sweat, and excess blood from the wound and skin before use. In fact, Navy Corpsmen who served with Marine combat units in Iraq reported they observed "second-degree burns" in Iraqi soldiers treated with this type of hemostatic methodology. Collagen. Collagen-like natural substances are created from chemically treated cellulose.
When they come in contact with blood, they expand to 3-4 times their original size and convert to a gel that dissolves into glucose and saline over a 1-2 week period. These materials contain no chemical additives, thrombin, or actual collagen, and they are hypoallergenic. Because of their purity and the fact that they simply degrade to these end products, they do not cause delayed healing as do other hemostatic materials that may have a similar appearance. ActCel, which is in a fabric-like state, increases platelet adhesion, thereby promoting clotting. This is similar to adherence of platelets to damaged collagen (the fibrous protein found in connective tissue that underlies the endothelial cells). ActCel stops bleeding quickly and effectively by adhering to the bleeding surface, physically blocking and sealing off the damaged blood vessels, expands to create direct pressure, transforms into a collagen-like gel that increases platelet aggregation and stabilizes clot formation, and is easily rinsed away with sterile water, saline, or hydrogen peroxide. Once ActCel has helped form a clot, it will dissolve into a glucose saline gel in 1-2 weeks (Bone, 2005) . Surgicel is primarily utilized for hemostatic wound management during surgical procedures. It has the ability to wrap around large vessels and stop severe bleeding during cardio and vascular procedures. In addition, the Surgicel product line has developed a variety of hemostatic materiel that ranges from a fiber-like substance to a liquid collagen and fibrin mixture for hard-to-reach direct applications. Surgicel is manufactured by the original makers of Gelfoam, which was an earlier hemostatic product utilized during surgery in the 1970s, '80s, and early '90s.
Pros Cons

Versatility; trauma and general surgery use Not specifically a trauma product
Absorbable Fibrous component may not degrade rapidly and may cause complications
Algae based. Algae-based coagulants primarily stimulate the body to produce its own coagulants (Paul & Sharma, 2004) . This stimulates platelet activation, which leads to the secretion of a substance known as thromboxane. Thromboxane stimulates the constriction of blood vessels near the wound, which helps slow blood flow there. These types of bandages are excellent for extremity wounds, most notably traumatic amputations. The properties of this -9 -coagulant allows a gelatin-like formation in the wound. As a result, bandages of this type prevent further trauma, pain, and hemorrhage due to their nonadherence. They provide a moist environment that leads to rapid granulation and re-epithelialization. In addition, algae-based coagulant properties are useful in split-thickness skin grafts required for burn patients. It is also excellent for applying these bandages on actual burn sites to promote healing. This substance comes from a single cell algae originating from the ocean.
Pros Cons
Excellent for extremity and burn trauma Price fluctuation According to company literature, Biolife's initial core brand is QR (Quick Relief) Powder, a wound dressing and highly cost-effective topical powder that stops bleeding instantly. It also acts as a protective barrier and bactericide to protect wounds. There are several other products, each with a specific use. For example, SuperQR is for major or severe wounds, UrgentQR is for minor wounds, NosebleedQR is for hydrophilic polymer nosebleeds, and OralQR is for oral wounds and to stop bleeding due to oral surgery and tooth extractions.
Biolife product literature states a 96% success rate in an ongoing clinical study treating lacerations, nosebleeds, skin tears, punctures, and abrasions. Normally, for minor wounds, no covering bandage is required.
Reasonable cost Superficial to moderate hemorrhage Addresses ear/nose/throat (ENT) and dental bleeding
Blister packs may not be suitable for tactical environment Absorbable Alternative packaging may be problematic
Instantly creates protective scab
Dry fibrin sealant dressing (DFSD).
This type of dressing is in an experimental phase. As indicated by its name, this dressing material is composed of dry fibrin (Travis, 1999) . It comes in a powder form and can be applied directly to the bleeding. The dry fibrin sealant dressing is In a 1-hour study, DFSD controlled exsanguinating hemorrhage from a large arterial injury as well as sutured repair. DFSD may provide hemorrhage control for exsanguinating extremity injuries until definitive repair.
Pros Cons
Developmental product for internal bleeding
Unable to assess at this time Literature guide. We also reviewed current literature and summarized products tested and study details in the table below as a quick reference guide. 
Conclusions
There are a variety of coagulant dressings on the market that can perform up to optimal standards and integrate well into the military's trauma and field medical materiel. However, the most noticeable characteristic is that not all coagulant dressings are the same. It is not merely a matter of one dressing being better than another. Some dressings are predominantly for extremity wounds; some perform better with burn trauma; some have the ability to control hemorrhage in hard-to-reach areas, such as mouth, dental, and ENT regions; some treat superficial wounds; and some have the ability to curtail internal bleeding. But no one dressing can do it all.
Therefore, to fully determine optimal hemorrhage control product performance, the simple solution of "one size fits all" may not be the answer. The information in this report provides a comprehensive list of coagulant products that the U.S. military medical community can evaluate and determine, based upon need, priority, and cost, which products will provide the best possible solutions for traumatic hemorrhage control in a battlefield environment.
